Interview: Aussie biotech on the cusp of big breakthrough

ASX-listed biotech Mesoblast is spoken about a lot on Fear and Greed due to its extremely volatile share price. This is largely tied to some big medical breakthroughs they've been working on for a long time.

Founder Silviu Itescu discusses the exhaustive and expensive process behind getting critical new drugs developed, tested and approved and the possible announcements that are coming.

Find out more: https://fearandgreed.com.au

See omnystudio.com/listener for privacy information.